LipidViro.com
Title
Lipidvirotech, Inc.
Description
Excerpted from the website:
- LipidViro Tech, Inc. (OTCBB: LPVT) is an early-stage biotechnology company engaged in research and commercial development of two primary platforms: d-OSAB Therapy, a treatment targeting cardiovascular disease and stroke; and PathPure, a purification process for production of pathogen-free biologics.
Languages
English